Regarding this issue, STAT1 overexpression is associated with IFN resistance in SCC cells [25], [28] and a third-generation bisphosphonate, YM529 which has almost equivalent antitumor effect to ZOL, augmented tumor-suppressive effects of IFN on RCC cells [13]. This evidence concerns the gene STAT1 and renal cell carcinoma.